HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Honokiol attenuates the severity of acute pancreatitis and associated lung injury via acceleration of acinar cell apoptosis.

Abstract
Severe acute pancreatitis remains a life-threatening disease with a high mortality rate among a defined proportion of those affected. Apoptosis has been hypothesized to be a beneficial form of cell death in acute pancreatitis. Honokiol, a low-molecular-weight natural product, possesses the ability of anti-inflammation and apoptosis induction. Here, we investigate whether honokiol can ameliorate severe acute pancreatitis and the associated acute lung injury in a mouse model. Mice received six injections of cerulein at 1-h intervals, then given one intraperitoneal injection of bacterial lipopolysaccharide for the induction of severe acute pancreatitis. Moreover, mice were intraperitoneally given vehicle or honokiol 10 min after the first cerulein injection. Honokiol protected against the severity of acute pancreatitis in terms of increased serum amylase and lipase levels, pancreas pathological injury, and associated acute lung injury. Honokiol significantly reduced the increases in serum tumor necrosis factor-α, interleukin 1, and nitric oxide levels 3 h and serum high-mobility group box 1 24 h after acute pancreatitis induction. Honokiol also significantly decreased myeloperoxidase activities in the pancreas and the lungs. Endoplasmic reticulum stress-related molecules eIF2α (phosphorylated) and CHOP protein expressions, apoptosis, and caspase-3 activity were increased in the pancreas of mice with severe acute pancreatitis, which was unexpectedly enhanced by honokiol treatment. These results suggest that honokiol protects against acute pancreatitis and limits the spread of inflammatory damage to the lung in a severe acute pancreatitis mouse model. The acceleration of pancreatic cell apoptosis by honokiol may play a pivotal role.
AuthorsTe I Weng, Hsiao Yi Wu, Bo Lin Chen, Shing Hwa Liu
JournalShock (Augusta, Ga.) (Shock) Vol. 37 Issue 5 Pg. 478-84 (May 2012) ISSN: 1540-0514 [Electronic] United States
PMID22258232 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biphenyl Compounds
  • Ddit3 protein, mouse
  • Enzyme Inhibitors
  • HMGB1 Protein
  • Interleukin-1beta
  • Lignans
  • Tumor Necrosis Factor-alpha
  • honokiol
  • Transcription Factor CHOP
  • Lipase
  • Amylases
  • Casp3 protein, mouse
  • Caspase 3
Topics
  • Acinar Cells (metabolism, pathology)
  • Acute Disease
  • Acute Lung Injury (complications, metabolism, pathology, prevention & control)
  • Amylases (metabolism)
  • Animals
  • Apoptosis (drug effects)
  • Biphenyl Compounds (pharmacology)
  • Caspase 3 (metabolism)
  • Disease Models, Animal
  • Endoplasmic Reticulum (metabolism, pathology)
  • Enzyme Inhibitors (pharmacology)
  • HMGB1 Protein
  • Interleukin-1beta (metabolism)
  • Lignans (pharmacology)
  • Lipase (metabolism)
  • Lung (metabolism, pathology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Pancreas (metabolism, pathology)
  • Pancreatitis (complications, metabolism, pathology, prevention & control)
  • Time Factors
  • Transcription Factor CHOP (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: